0001104659-20-080567.txt : 20200702 0001104659-20-080567.hdr.sgml : 20200702 20200702161711 ACCESSION NUMBER: 0001104659-20-080567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Partners Innovation Fund II, L.P. CENTRAL INDEX KEY: 0001689717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39343 FILM NUMBER: 201009543 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-307-2400 MAIL ADDRESS: STREET 1: 215 FIRST STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akouos, Inc. CENTRAL INDEX KEY: 0001722271 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-245-5715 MAIL ADDRESS: STREET 1: 645 SUMMER STREET, SUITE 200 CITY: BOSTON STATE: MA ZIP: 02210 4 1 a4.xml 4 X0306 4 2020-06-30 1 0001722271 Akouos, Inc. AKUS 0001689717 Partners Innovation Fund II, L.P. 215 FIRST STREET, SUITE 500 CAMBRIDGE MA 02142 0 0 1 0 Common Stock 2020-06-30 4 C 0 68501 A 68501 D Common Stock 2020-06-30 4 C 0 228336 A 296837 D Common Stock 2020-06-30 4 C 0 79998 A 376835 D Series Seed Preferred Stock 2020-06-30 4 C 0 68501 0.00 D Common Stock 68501 0 D Series A Preferred Stock 2020-06-30 4 C 0 228336 0.00 D Common Stock 228336 0 D Series B Preferred Stock 2020-06-30 4 C 0 79998 0.00 D Common Stock 79998 0 D On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC is the ultimate general partner of PIF II. On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. /s/ Partners Innovation Fund II, L.P. By: Julius Knowles, Authorized Signatory 2020-07-02